Evolution of the Physical Condition in Treated Cancer Patients
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 300
- 试验地点
- 2
- 主要终点
- evolution of exercise tolerance
研究概览
简要总结
Adaptated Physical Activity (APA) during treatment of cancer is one of the actual global health recommendation because of the benefits observed in several parameters evaluated in many clinical studies. A best knowledge of the physical and medical characteristics of patients, including type of cancer and type of treatment, is primordial to optimize the patient care and the effectiveness of APA programs.
Descriptive, explorative and prospective study of 3 different populations:
One population with locally advanced or metastatic non-small cell lung cancer treated with multiple therapeutic lines. Two different populations of early cancer patients and treated with a platinum-based regimen for colon cancer and a taxane-based chemotherapy for breast cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Woman with breast cancer treated with adjuvant chemotherapy (taxane) or patient with colon cancer treated with adjuvant regimen (FOLFOX) or patient with locally advanced or metastatic lung cancer
- •Patient without contraindication to the study-specific assessments
- •Eastern Cooperative Oncology Group ≤ 2
- •Age ≥ 18 years old
- •Life expectancy > 6 months
- •Able to speak, read and understand French
- •Written informed consent obtained from the patient
- •Registration in a national health care system
排除标准
- •Patient with psychiatric, neurologic or musculoskeletal disorders
- •Pregnant or breastfeeding women
- •Minor or protected adult
结局指标
主要结局
evolution of exercise tolerance
时间窗: change from baseline exercise tolerance at 12 weeks after the end of the treatment
To describe exercise tolerance, by a six-minute walk test, in patients treated for a cancer (of lung, breast or colon) after 8 weeks of treatment.
次要结局
- measurement of the lean body mass condition(change from baseline physical condition at 12 weeks after the end of the treatment)
- measurement of the pulmonary function(change from baseline physical condition at 12 weeks after the end of the treatment)
- measurement of parameters reflecting the physical condition(change from baseline physical condition at 12 weeks after the end of the treatment)